RTI Biologics receives 510(k) clearance for porcine dermis Implant RTI Biologics has received 510(k) clearance from the FDA for its porcine dermis implant. The implant is intended for use in soft tissue repair procedures such as hernia repair. The implants will be processed at RTIís facility in Neunkirchen, Germany for commercial distribution in the U.S. later this year. The facility has begun production of the implants.
News For RTIX From The Last 14 Days
Check below for free stories on RTIX the last two weeks.
RTI Surgical receives CE Mark approval for Fortiva Porcine Dermis RTI Surgical that the company received approval to CE mark Fortiva Porcine Dermis and will begin distribution throughout Europe. Fortiva received 510(k) clearance from the FDA in March 2013 and was launched in the U.S. in July 2013. The implant is manufactured at RTIís Neunkirchen, Germany facility.